AZ's antibody treatment halves risk of death, severe illness; Merck asks FDA to OK antiviral pill
(Newser) -
Good news on the AstraZeneca front, though not about its vaccine. Per Reuters , the UK drugmaker announced Monday that its AZD7442 antibody treatment, meant to be injected into patients showing symptoms of COVID, led to a "statistically significant reduction in severe COVID-19 or death," compared to mildly to...